Topics
News
CME/CE
Editorial Advisory Board
Partnerships
Understanding the benefits of p16 testing for high-risk familial melanoma patients
P16-mutation carriers are at extremely high risk for developing melanoma. Many high-risk melanoma clinics worldwide are reporting genetic test results, and clinical testing also is increasing in the United States. There are currently no guidelines regulating genetic testing in the United States, but melanoma genetics experts are working to develop meaningful guidelines that will, hopefully, be published in early 2008.
Related Videos
Related Content
